📰 Illness Scale News
Illness Scale News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Illness Scale. Real-time updates on events, politics, business and more.
February 2, 2024
Recent research highlighted the potential role of an atypical antipsychotic to treat anxiety — a prevalent and undertreated symptom in BPD that comes without the typical metabolic side effects.
June 13, 2023
Data showed good news for safety and tolerability with mixed good news for efficacy.
July 27, 2022
This analysis explored the relationship between AS engagement by participants and changes in participant performance and symptom-severity measures.
May 23, 2022
The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.
May 20, 2022
The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.
May 3, 2022
The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.
May 2, 2022
New selective norepinephrine reuptake inhibitor is no longer just for kids
January 28, 2022
A review of the research literature finds a positive association between uncertainty and mental distress such as depression and anxiety.
December 29, 2021
Illness uncertainty, self-perceived burden, and QOL should be regularly assessed in patients with CML, with extra attention to illness uncertainty due to its importance in QOL.
September 8, 2021
The FDA has accepted for review the sNDA for viloxazine extended-release (Qelbree) for the treatment of ADHD in adults.